# The Value of Methotrexate in NCES for Stable Vitiligo

> **NCT07352293** · PHASE4 · RECRUITING · sponsor: **Cairo University** · enrollment: 20 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **PROCEDURE:** Non cultured epidermal suspension

## Key facts

- **NCT ID:** NCT07352293
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-03
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352293, "The Value of Methotrexate in NCES for Stable Vitiligo". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07352293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*